AffiAB® Anti-PI3-kinase p110 subunit beta Antibody [SC0580]
Phosphatidylinositol 3-kinase (PI 3-kinase) is composed of p85 and p110 subunits. p85 lacks PI 3-kinase activity and acts as an adapter, coupling p110 to activated protein tyrosine kinase. Two forms of p85 have been described (p85α and p85β) , each possessing one SH3 and two SH2 domains. Various p110 isoforms have been identified. p110α and p110β interact with p85α, and p110α has also been shown to interact with p85β in vitro. p110 expression is restricted to white blood cells. It has been shown to bind p85α and β, but it apparently does not phosphorylate these subunits. p110δ seems to have the capacity to autophosphorylate. p110γ does not interact with the p85 subunits. It has been shown to be activated by α and β γ heterotrimeric G proteins.
Antibody type
Recombinant Rabbit monoclonal Antibody
Uniprot ID
SwissProt: P42338 Human
Recombinant
YES
Conjugation
Non-conjugated
Host
Rabbit
Isotype
IgG
Clone
SC0580
KO/KD
N/A
Species reactivity
Human
Tested applications
WB, IP, IHC-P, FC
Predicted species reactivity
N/A
Immunogen
Synthetic peptide within Human PIK3CB aa 5-52 / 1070.
Storage
Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
Form
Liquid
Storage buffer
1*TBS (pH7.4) , 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Concentration
1 mg/mL.
Purity
Protein A affinity purified.
Signal pathway
VEGF signaling pathway, HIF-1 signaling pathway, PI3K-AKT, 衰老, ErbB signaling pathway, RAS signaling pathway, Phosphatidylinositol signaling, JAK-STAT signaling pathway, Immunology & Inflammation, Alzheimer disease, Apotosis, cAMP signaling pathway, AMPK signaling pathway
Recommended dilutions
WB: 1:1, 000
; IHC-P: 1:50-1:100
; FC: 1:50-1:100
; IP: Use at an assay dependent concentration.
Molecular Weight
123 kDa
Subcellular location
Cytoplasm, Nucleus.
Positive control
Hela cell lysates, human liver carcinoma tissue, Hela.